Difference between revisions of "Cyberdyne HAL"

From HCE Wiki - The Human Cognitive Enhancement Wiki
Jump to navigation Jump to search
(created; added infobox, added template; added into categories)
 
(a correction)
 
(24 intermediate revisions by one other user not shown)
Line 1: Line 1:
 
{{BodyWornWearables|
 
{{BodyWornWearables|
name_of_device=###|
+
name_of_device=Hybrid Assistive Limb|
image_file_name=###|
+
image_file_name=Cyberdynehal 01.jpg|
category=###|
+
category=Limb-mounted|
developer=###|
+
developer=Cyberdyne|
developer_commentary=###|
+
developer_commentary=<ref>http://cyberdyne.jp/english/company/Recruit.html</ref>|
announced=###|
+
announced=1997|
announced_commentary=###|
+
announced_commentary=(prototype)<ref>http://web-japan.org/nipponia/nipponia38/en/feature/feature02.html</ref>|
developer_release=###|
+
developer_release=|
developer_release_commentary=###|
+
developer_release_commentary=|
consumers_release=###|
+
consumers_release=|
consumers_release_commentary=###|
+
consumers_release_commentary=(not released)|
price=###|
+
price=2000|
price_commentary=###|
+
price_commentary=(monthly)<ref>http://www.theaustralian.com.au/news/world/robots-to-the-rescue-as-an-aging-japan-looks-for-help/story-e6frg6so-1226494698495</ref>|
operating_system=###|
+
operating_system=|
operating_system_commentary=###|
+
operating_system_commentary=(unknown)|
sensors1=###|
+
sensors1=bio-electric signals|
sensors_commentary=###|
+
sensors_commentary=<ref name="lowerlimbnonmedical" />|
weight=###|
+
weight=12000 |
weight_commentary=###|
+
weight_commentary=(Lower-limb model, both legs)<ref name="lowerlimbnonmedical">http://www.cyberdyne.jp/english/products/LowerLimb_nonmedical.html</ref>|
controls1=###|
+
controls1=user's brain signals|
controls_commentary=###|
+
controls_commentary=<ref>http://www.ccr-deutschland.de/en/healthcare/</ref>|
data_available=###|
+
data_available=Limited|
risk_factor=###|
+
risk_factor=Low|
standalone_not_standalone=Standalone-Not Standalone|
+
standalone_not_standalone=Standalone|
link_to_website=###|
+
link_to_website=http://www.cyberdyne.jp/english/|
 
}}
 
}}
  
<!-- Very brief description of the technology. This section should contain the main information about the subject. It's good to leave this bit as the last one and use the information provided in greater detail in later sections.-->
+
Cyberdyne Hybrid Assistive Limb, or HAL, is a powered, wearable exoskeleton designed to support and assist the muscles of the user. It is used to return the ability to move to persons who lost it due to spinal injury or a stroke. It can be used in mobility therapy and restoration, movement assistance for the elderly, and movement and strength enhancement for workers or incident response teams.
  
== Main characteristics ==
+
== Main Characteristics ==
<!-- This section should describe the technology in more detail. Here should be information about the used hardware and software, available features, chemical composition and so on, provided that they are available. Second half of this section should offer information on history of the technology. When it was created, unveiled, developed, announced to the public or when it was available to purchase. Anything related to the technology that can be pinpointed to a certain date should be in this section together with relevant commentary.-->
+
[[File:CyberdyneHAL 02.jpg|thumbnail|Man showcasing the device.]]
 +
Cyberdyne HAL is equipped with neurosignal sensors that pick up the neural signals from the user's spine and translate them into the movement of the motorized joints. The user is only required to think about moving their limbs. HAL is currently used in neuromuscular feedback therapy. There are also plans to develop a powered exoskeleton to enhance workers working with heavy weights,<ref>http://www.ccr-deutschland.de/en/2015/07/09/ondersteuning-van-de-arbeid/</ref> or powered and protective exoskeleton for emergency and disaster responders.<ref>http://www.cyberdyne.jp/english/products/supporting.html</ref> The company claims that it will never develop technology for military purposes.<ref name="forbes">http://www.forbes.com/sites/jsimms/2015/04/01/yoshiyuki-sankais-cyborgs-serve-japans-sick-and-elderly/2/#28a184cd2134</ref>
  
 
=== Purpose ===
 
=== Purpose ===
<!-- This is a very short description of the technology's purpose. What will it be doing, for what goal was it created, how it modifies human cognition. Keep this as brief as possible. -->
+
 
 +
Cyberdyne HAL is a powered exoskeleton used in mobility therapy and for movement and strength enhancement.
  
 
=== Company & People ===
 
=== Company & People ===
<!-- This is a list of important people behind the technology. Note: It is not necessary to list absolutely everyone. -->
+
 
 +
The exoskeleton is developed by a Japanese company Cyberdyne Inc. The company was founded on 24 June 2004 and is headquartered in Tsukuba, Japan.<ref>http://www.cyberdyne.jp/english/company/index.html</ref><ref>http://quotes.wsj.com/JP/XTKS/7779</ref>
 +
 
 +
* Professor Yoshiyuki Sankai - President and founder
 +
* Fumiyuki Ichihashi, Shinji Uga, Hiroaki Kawamoto - Directors
 
   
 
   
 
== Important Dates ==
 
== Important Dates ==
<!-- A list of important dates in the development and history of the technology. Use the information provided in the second half of the Main characteristics section and make it into a short, unnumbered list. -->
+
 
 +
April 2016 - Keio University joins Cyberdyne to develop treatments for spinal cord injuries that combine induced pluripotent stem cell therapy and Cyberdyne's exoskeleton therapy.<ref>http://asia.nikkei.com/Tech-Science/Tech/Robotic-suit-iPS-therapy-to-be-tried-in-spinal-cord-rehab</ref>
  
 
== Enhancement/Therapy/Treatment ==
 
== Enhancement/Therapy/Treatment ==
<!-- Describe in detail whether the technology aims to enhance human cognition, i.e. to improve human abilities beyond what is considered normal, and/or if it is also applicable as a form of treatment or therapy, i.e. it can serve to cure patients or restore abilities that do not perform as they would in a healthy person -->
+
 
 +
Enhancement & Therapy - The exoskeleton can be used to restore the ability to walk in spinal cord injuries patients and it can be also used to enhance the strength of a healthy human beyond their natural capabilities.
  
 
== Ethical & Health Issues ==
 
== Ethical & Health Issues ==
<!-- Provide detailed information (if possible or if available) about any ethical risks and related ethical topics, and also related health issues, be it already discovered and covered in literature, or just speculative ones, should be described and properly cited in this section. -->
+
 
 +
We recorded no ethical or health issues connected to this particular device.
 +
 
 +
For more general issues connected with smartglasses, please see the [[Body-worn Wearables]] synopsis.
  
 
== Public & Media Impact and Presentation ==
 
== Public & Media Impact and Presentation ==
<!-- Provide information about the impact the technology had on the public and how the technology is presented in the media or literature. If there was anything in the news regarding this technology, it should be noted and properly cited here. -->
+
 
 +
The company lists a number media articles on their website.<ref>http://www.cyberdyne.jp/english/company/Media_list.html</ref> The following is a digest of some of the selected articles about the device:
 +
 
 +
An article in the Nikkei Asian Review talks about the financial difficulties the company had in the fiscal year of 2015. According to the news piece, investors are reluctant to buy Cyberdyne's shares because it failed to show new plans on how to expand their business. The high R&D costs greatly limited the company's net gain in finances. The article further talks about the company plans to expand into Europe with the medical-grade version of the device and informs that despite this expansion, Cyberdyne was not met with greatly increased financial gain.<ref>http://asia.nikkei.com/Japan-Update/Japan-s-Cyberdyne-sees-US-as-path-to-profit?page=1</ref>
 +
 
 +
Forbes Asia writes about the history of the company and its founder. It mentions the company's plans to expand their product portfolio with non-medical variants of the HAL exoskeleton. The article also mentions that Cyberdyne trusts their vision enough that it expects its revenue to double in the following two years and that it expects the income to continue to rise as the Japan's population ages.<ref>http://www.forbes.com/sites/jsimms/2015/04/01/yoshiyuki-sankais-cyborgs-serve-japans-sick-and-elderly/#2059c4f71d54</ref>
 +
 
 +
Story in the Bloomberg magazine focuses on Japan's robotic research and mentions Cyberdyne as one of the firms "pushing the boundaries". The article shares Cyberdyne's founder history. It also mentions that HAL has been introduced into Tokiwa Koutai Co., an aluminium processing factory, to help workers handle heavy loads.<ref>http://www.bloomberg.com/news/articles/2015-09-13/in-japan-the-rise-of-the-machines-solves-labor-and-productivity</ref>
 +
 
 +
BBC News also covered Japan's robotic technology. In an article title 'Meeting the pioneers of Japan's coming robot revolution', they covered Cyberdyne HAL's abilities to restore the ability to walk in a Poliomyelitis patient and an amputee. The authors closed the article with saying that the technology was still in its infancy and that Cyberdyne works on a lighter model that could be worn by children.<ref>http://www.bbc.com/news/world-asia-pacific-34272425</ref>
 +
 
 +
The Wall Street Journal featured a long article about Japan dealing with its ageing population. The article mentions technology, and robotics specifically, as solutions for the upcoming demographic shift. The article mentions that Cyberdyne leased its exoskeletons to the Fujisawa Aikoen nursing home.<ref>http://www.wsj.com/articles/graying-japan-tries-to-embrace-the-golden-years-1448808028</ref>
  
 
== Public Policy ==
 
== Public Policy ==
<!-- Information related to any regulations (law, patents, ISOs, government recommendations and so on.) -->
 
  
== Related Technologies, Projects or Scientific Research ==
+
There is no policy regarding this particular device. However, policies relevant to [[Body-worn Wearables]] may apply to this device too.
<!-- If there is any scientific research conducted or being conducted that is closely connected to this technology, it should be properly cited here. -->
+
 
 +
== Related Technologies, Projects, or Scientific Research ==
 +
 
 +
http://www.ncbi.nlm.nih.gov/pubmed/?term=HAL%C2%AE+exoskeleton+training+improves+walking+parameters+and+normalizes+cortical+excitability+in+primary+somatosensory+cortex+in+spinal+cord+injury+patients.
 +
 
 +
http://www.ncbi.nlm.nih.gov/pubmed/24704677
 +
 
 +
http://www.ncbi.nlm.nih.gov/pubmed?term=Factors%20Predicting%20the%20Effects%20of%20Hybrid%20Assistive%20Limb%20Robot%20Suit%20during%20the%20Acute%20Phase%20of%20Central%20Nervous%20System%20Injury.
 +
 
 +
http://www.ncbi.nlm.nih.gov/pubmed/?term=Modification+of+hemiplegic+compensatory+gait+pattern+by+symmetry-based+motion+controller+of+HAL.
 +
 
 +
http://www.ncbi.nlm.nih.gov/pubmed/?term=HAL%C2%AE+exoskeleton+training+improves+walking+parameters+and+normalizes+cortical+excitability+in+primary+somatosensory+cortex+in+spinal+cord+injury+patients.
 +
 
 +
http://www.ncbi.nlm.nih.gov/pubmed/?term=Feasibility+and+efficacy+of+high-speed+gait+training+with+a+voluntary+driven+exoskeleton+robot+for+gait+and+balance+dysfunction+in+patients+with+chronic+stroke%3A+nonrandomized+pilot+study+with+concurrent+control.
 +
 
 +
http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1545505
 +
 
 +
http://www.tandfonline.com/doi/abs/10.3109/17483107.2015.1129455
 +
 
 +
http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=5953292&tag=1
 +
 
 +
http://link.springer.com/chapter/10.1007/978-3-642-34546-3_36#page-1
  
 
== References ==
 
== References ==

Latest revision as of 13:35, 14 July 2017

Hybrid Assistive Limb
Cyberdynehal 01.jpg
Category Limb-mounted
Developer Cyberdyne [1]
Announced 1997 (prototype)[2]
Released Developers:
Consumers: (not released)
Price 2000 USD (monthly)[3]
Operating system (unknown)
Sensors

bio-electric signals [4]

Weight 12000 g (Lower-limb model, both legs)[4]
Controls

user's brain signals [5]

Data available Limited
Risk factor Low
Standalone
http://www.cyberdyne.jp/english/

Cyberdyne Hybrid Assistive Limb, or HAL, is a powered, wearable exoskeleton designed to support and assist the muscles of the user. It is used to return the ability to move to persons who lost it due to spinal injury or a stroke. It can be used in mobility therapy and restoration, movement assistance for the elderly, and movement and strength enhancement for workers or incident response teams.

Main Characteristics

Man showcasing the device.

Cyberdyne HAL is equipped with neurosignal sensors that pick up the neural signals from the user's spine and translate them into the movement of the motorized joints. The user is only required to think about moving their limbs. HAL is currently used in neuromuscular feedback therapy. There are also plans to develop a powered exoskeleton to enhance workers working with heavy weights,[6] or powered and protective exoskeleton for emergency and disaster responders.[7] The company claims that it will never develop technology for military purposes.[8]

Purpose

Cyberdyne HAL is a powered exoskeleton used in mobility therapy and for movement and strength enhancement.

Company & People

The exoskeleton is developed by a Japanese company Cyberdyne Inc. The company was founded on 24 June 2004 and is headquartered in Tsukuba, Japan.[9][10]

  • Professor Yoshiyuki Sankai - President and founder
  • Fumiyuki Ichihashi, Shinji Uga, Hiroaki Kawamoto - Directors

Important Dates

April 2016 - Keio University joins Cyberdyne to develop treatments for spinal cord injuries that combine induced pluripotent stem cell therapy and Cyberdyne's exoskeleton therapy.[11]

Enhancement/Therapy/Treatment

Enhancement & Therapy - The exoskeleton can be used to restore the ability to walk in spinal cord injuries patients and it can be also used to enhance the strength of a healthy human beyond their natural capabilities.

Ethical & Health Issues

We recorded no ethical or health issues connected to this particular device.

For more general issues connected with smartglasses, please see the Body-worn Wearables synopsis.

Public & Media Impact and Presentation

The company lists a number media articles on their website.[12] The following is a digest of some of the selected articles about the device:

An article in the Nikkei Asian Review talks about the financial difficulties the company had in the fiscal year of 2015. According to the news piece, investors are reluctant to buy Cyberdyne's shares because it failed to show new plans on how to expand their business. The high R&D costs greatly limited the company's net gain in finances. The article further talks about the company plans to expand into Europe with the medical-grade version of the device and informs that despite this expansion, Cyberdyne was not met with greatly increased financial gain.[13]

Forbes Asia writes about the history of the company and its founder. It mentions the company's plans to expand their product portfolio with non-medical variants of the HAL exoskeleton. The article also mentions that Cyberdyne trusts their vision enough that it expects its revenue to double in the following two years and that it expects the income to continue to rise as the Japan's population ages.[14]

Story in the Bloomberg magazine focuses on Japan's robotic research and mentions Cyberdyne as one of the firms "pushing the boundaries". The article shares Cyberdyne's founder history. It also mentions that HAL has been introduced into Tokiwa Koutai Co., an aluminium processing factory, to help workers handle heavy loads.[15]

BBC News also covered Japan's robotic technology. In an article title 'Meeting the pioneers of Japan's coming robot revolution', they covered Cyberdyne HAL's abilities to restore the ability to walk in a Poliomyelitis patient and an amputee. The authors closed the article with saying that the technology was still in its infancy and that Cyberdyne works on a lighter model that could be worn by children.[16]

The Wall Street Journal featured a long article about Japan dealing with its ageing population. The article mentions technology, and robotics specifically, as solutions for the upcoming demographic shift. The article mentions that Cyberdyne leased its exoskeletons to the Fujisawa Aikoen nursing home.[17]

Public Policy

There is no policy regarding this particular device. However, policies relevant to Body-worn Wearables may apply to this device too.

Related Technologies, Projects, or Scientific Research

http://www.ncbi.nlm.nih.gov/pubmed/?term=HAL%C2%AE+exoskeleton+training+improves+walking+parameters+and+normalizes+cortical+excitability+in+primary+somatosensory+cortex+in+spinal+cord+injury+patients.

http://www.ncbi.nlm.nih.gov/pubmed/24704677

http://www.ncbi.nlm.nih.gov/pubmed?term=Factors%20Predicting%20the%20Effects%20of%20Hybrid%20Assistive%20Limb%20Robot%20Suit%20during%20the%20Acute%20Phase%20of%20Central%20Nervous%20System%20Injury.

http://www.ncbi.nlm.nih.gov/pubmed/?term=Modification+of+hemiplegic+compensatory+gait+pattern+by+symmetry-based+motion+controller+of+HAL.

http://www.ncbi.nlm.nih.gov/pubmed/?term=HAL%C2%AE+exoskeleton+training+improves+walking+parameters+and+normalizes+cortical+excitability+in+primary+somatosensory+cortex+in+spinal+cord+injury+patients.

http://www.ncbi.nlm.nih.gov/pubmed/?term=Feasibility+and+efficacy+of+high-speed+gait+training+with+a+voluntary+driven+exoskeleton+robot+for+gait+and+balance+dysfunction+in+patients+with+chronic+stroke%3A+nonrandomized+pilot+study+with+concurrent+control.

http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1545505

http://www.tandfonline.com/doi/abs/10.3109/17483107.2015.1129455

http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=5953292&tag=1

http://link.springer.com/chapter/10.1007/978-3-642-34546-3_36#page-1

References